These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32692101)

  • 1. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    Sevelius JM; Poteat T; Luhur WE; Reisner SL; Meyer IH
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):437-442. PubMed ID: 32692101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
    Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
    Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Social Support in HIV Testing and PrEP Awareness among Young Black Men and Transgender Women Who Have Sex with Men or Transgender Women.
    Lelutiu-Weinberger C; Wilton L; Koblin BA; Hoover DR; Hirshfield S; Chiasson MA; Nandi V; Usher D; Frye V
    J Urban Health; 2020 Oct; 97(5):715-727. PubMed ID: 31898199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-exposure Prophylaxis Awareness and Use Among Transgender and Nonbinary Individuals in Canada.
    Hallarn J; Scheim AI; Bauer GR
    J Acquir Immune Defic Syndr; 2024 Aug; 96(4):341-349. PubMed ID: 38916428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
    Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
    AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
    J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
    Malone J; Reisner SL; Cooney EE; Poteat T; Cannon CM; Schneider JS; Radix A; Mayer KH; Haw JS; Althoff KN; Wawrzyniak AJ; Beyrer C; Wirtz AL;
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):10-18. PubMed ID: 34397742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
    Cooney EE; Saleem HT; Stevenson M; Aguayo-Romero RA; Althoff KN; Poteat TC; Beckham SW; Adams D; Radix AE; Wawrzyniak AJ; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Mayer KH; Beyrer C; Reisner SL; Wirtz AL;
    J Int AIDS Soc; 2023 Dec; 26(12):e26199. PubMed ID: 38123897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
    Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
    PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men.
    Eaton LA; Kalichman SC; Price D; Finneran S; Allen A; Maksut J
    AIDS Behav; 2017 May; 21(5):1236-1246. PubMed ID: 28108878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020.
    Morris E; Teplinskaya A; Olansky E; Rinderle JK; Chapin-Bardales J;
    MMWR Suppl; 2024 Jan; 73(1):9-20. PubMed ID: 38261546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrEP Uptake and Discontinuation Among a U.S. National Sample of Transgender Men and Women.
    Zarwell M; John SA; Westmoreland D; Mirzayi C; Pantalone DW; Golub S; Nash D; Grov C
    AIDS Behav; 2021 Apr; 25(4):1063-1071. PubMed ID: 33057893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Testing and Preexposure Prophylaxis Prescriptions Among U.S. Commercially Insured Transgender Men and Women, 2014 to 2021.
    Huang YA; Radix A; Zhu W; Kimball AA; Olansky EJ; Hoover KW
    Ann Intern Med; 2024 Jan; 177(1):12-17. PubMed ID: 38109739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV testing and pre-exposure prophylaxis (PrEP) use, familiarity, and attitudes among gay and bisexual men in the United States: A national probability sample of three birth cohorts.
    Hammack PL; Meyer IH; Krueger EA; Lightfoot M; Frost DM
    PLoS One; 2018; 13(9):e0202806. PubMed ID: 30192791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV awareness and prevention strategies among transgender women in the Eastern and Southern United States: findings from the LITE Study.
    Aguayo-Romero RA; Cannon CM; Wirtz AL; Cooney EE; Mayer KH; Reisner SL;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25999. PubMed ID: 36225140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.